Int J Biol Sci 2021; 17(11):2770-2771. doi:10.7150/ijbs.63969 This issue

Commentary

Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?

Salvatore Santamaria

Department of Immunology and Inflammation, Imperial College London, Du Cane Road W12 0NN, London, UK.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Santamaria S. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. Int J Biol Sci 2021; 17(11):2770-2771. doi:10.7150/ijbs.63969. Available from https://www.ijbs.com/v17p2770.htm

File import instruction

Commentary-article in Int J Biol Sci, Volume 17, 2348

Abstract

Graphic abstract

Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.

Keywords: SARS-CoV-2, COVID-19, PI3K/AKT pathway